We're genuinely excited about the future, as clinical trials are evolving out of necessity. They need to be more diversified and inclusive. As Larry mentioned today, clinical trials have often been concentrated in large, university-led systems, which served us well for many years. But COVID changed everything, disrupting this traditional approach. In a pandemic that impacted everyone, it became clear that clinical trials must adapt to reflect and address the diverse populations they aim to serve